Novogenia AG (MUN: 7V0)
Health Care · Biotechnology · DE
€7.20
— today · +9.9% 1Y
Novogenia AG (MUN: 7V0) operates in the Biotechnology industry within the Health Care sector. The company is valued at $98.11M.
Over the last twelve months the share price has gained 9.9%, trading between 5.70 and 11.80.
Tweenvest scores Novogenia AG across four factors: quality 65/100, value 76/100, dividend 100/100. Its strongest factor is dividend.
7V0 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $98.11M
- Revenue (TTM)
- $59.81M
- P/E
- —
- EPS
- -0.29
- Dividend yield
- 7.81%
- Beta (5Y)
- 0.26
- 52-week high
- €11.80
- 52-week low
- €5.70
- Avg volume (3M)
- —
- Shares outstanding
- 12.00M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cellectis S.A.ENXTPA: ALCLS | $99.91M | €1.23 | -2.07% |
| Faron Pharmaceuticals OyAIM: FARN | $99.74M | £0.37 | +5.19% |
| Pet Pharm Biotech Co., Ltd.TPEX: 7762 | $99.39M | NT$54.50 | +2.44% |
| SynAct Pharma ABOM: SYNACT | $99.32M | Skr16.90 | -5.06% |
| Y-Biologics, Inc.KOSDAQ: A338840 | $97.21M | ₩8,520.00 | +2.16% |
| Senhwa Biosciences, Inc.TPEX: 6492 | $96.53M | NT$34.40 | +0.58% |
| Medivir AB (publ)OM: MVIR | $96.31M | Skr1.55 | -2.15% |
| Biomea Fusion, Inc.NasdaqGS: BMEA | $95.68M | $1.37 | +3.79% |
Figures last refreshed Oct 4, 2026.